Clinical Trial NCT04434092
Trial
Roche – BO42162 COMMODORE 2 (NCT04434092)
Clinical trial ID
NCT04434092
Drug name
Crovalimab
Company:
Roche
Drug trade name
---
Clinicaltrials.gov
Learn more
Phase of study
3
Current status
Active, not recruiting
Start
10/2020
Substance
Monoclonal antibody
Research question
Versus eculizumab, treament-naive
Delivery method of drug
Single i.v./then s.c.
Frequency
Every 4 weeks
Clinical trial locations
Argentina Australia Brazil China France Germany Greece Hong Kong Japan Lithuania Malaysia Mexico Netherlands Philippines Poland Portugal Romania Singapore South Africa